Please assess the completion status of the following clinical trial:

Trial Title: Second-line Therapy of Unresectable Cholangiocarcinoma by RADIOEMBOLIZATION

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE1/PHASE2
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Unresectable intra-hepatic CCK histologically proven~* Tumor progression documented on imaging evaluation ( CT or MRI) according to RECIST criteria version 1.1 after first-line therapy~* Performance status \< 2 ; 4) Bilirubin \< 36 micromol/l~* age \> 18 years~Exclusion Criteria:~* Extra-hepatic metastases~* Uncontrolled biliary obstruction~* Contra-indications to RE.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- 1 (Type: EXPERIMENTAL): Yttrium microsphere injection

Based on this trial design, predict the completion outcome and termination type (if applicable).